BioSpace News Archive

Mind Medicine today announced the first patient has been dosed in a Phase 1 investigator-initiated study led by MindMed collaborator Prof. Dr. Matthias Liechti at University Hospital Basel (UHB).

Virax Biolabs announced today the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union.

Invitae and Praxis Precision Medicines , Inc. today announced that real-world clinical insights from Invitae’s Ciitizen platform were utilized as natural history data to support the submission of Praxis’ Investigational New Drug (IND) application for PRAX-222 for the treatment of pediatric patients with early-onset SCN2A developmental and epileptic encephalopathy (DEE).

Intuity Medical, Inc. announced that the POGO Automatic® Blood Glucose Monitoring System and POGO Automatic® Test Cartridges are now available with discount pricing through the Costco Member Prescription Program.

Think Research Corporation has signed multiple new contracts in the third quarter worth approximately $12.8 million.

Ludwig Enterprises is pleased to announce that the Company has started discussions with Emerson Urology Associates, Concord, MA regarding initiation of a clinical study to evaluate the response of bladder cancer patients to BCG immunotherapy.

CytoReason announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence technology for Pfizer’s drug development programs.

Albireo Pharma, Inc. announced participation in the Guggenheim Therapeutics Conference in Nantucket, MA, from September 27-29, 2022.

Orchestra BioMed™, Inc. announced the presentation of positive long-term clinical results from the MODERATO II Control Patients Crossover Extension Study of BackBeat Cardiac Neuromodulation Therapy™ at the Transcatheter Cardiovascular Therapeutics 2022 annual conference being held in Boston, MA.

Elicio Therapeutics announced that it has been awarded a $2.8 million grant from the Gastro-Intestinal Research Foundation in Chicago to fund research for two therapeutic cancer vaccines.